CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops an automated system for cell and gene therapy manufacturing, focusing on in-line monitoring of critical process parameters. By integrating miniaturized biosensors with a bioreactor, it aims to standardize and streamline production, making therapies more accessible and cost-effective for patients.
Problem:
Cell and gene therapies (CGT) represent a breakthrough in the treatment of a wide range of conditions.
However, limited global manufacturing capacity owing to a lack of scalability prevents CGT from becoming widely available to patients: therapies are prepared individually at central facilities in a series of complex open manual steps.
Variability is high, and a uniform manufacturing process is lacking.
Automated, standardized, quality-controlled, and decentralized processes are urgentl…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, FREIBURG IM BREISGAU
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Portugal, Barco Gmr
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Austria, Wien
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Belgium, Jumet
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
